Every parent wants to know their child is protected. A new surveillance report from the National Immunization Survey-Child gives us a look at how many toddlers in the United States are getting their recommended vaccines by their second birthday. It focuses on children born in 2019 and 2020, tracking not just overall vaccination coverage but also disparities in who is getting these shots. This is purely observational data—it describes what's happening in communities, not the effects or safety of the vaccines themselves. The specific numbers on coverage and the size of any gaps aren't reported in the available summary, so we can't yet say how the picture has changed. What it does provide is a crucial temperature check on our public health system for young children.
Surveillance report describes vaccination coverage by age 24 months in US childrenHow many toddlers are getting their recommended vaccines? New data tracks coverage
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This observational surveillance report from the United States used data from the National Immunization Survey-Child to examine vaccination coverage by age 24 months. The population studied was children born in 2019 and 2020. The report also aimed to assess disparities in coverage. No comparator group was specified in the provided information.
The primary outcome was vaccination coverage by age 24 months. The report did not provide specific numerical results for this outcome, such as coverage percentages, absolute numbers, effect sizes, or statistical confidence intervals. The direction of any trends or differences was also not reported. Secondary outcomes included an assessment of disparities in vaccination coverage.
No safety, tolerability, or adverse event data from the surveillance were reported. Key limitations include the observational nature of the data, which can only describe associations and patterns, not prove causation. The specific funding sources and potential conflicts of interest were not reported. The practice relevance of the findings is limited without specific coverage rates or detailed analyses of disparities, but the report highlights ongoing monitoring of childhood vaccination trends.
View Original Abstract ↓
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma
New Asthma Drug Cuts Attacks Without Recent Crisis
Related in Allergy & Immunology
From Other Specialties
